|
11
|
|
GENETICALLY ENGINEERED SALMONELLA TYPHIMURIUM FOR CANCER THERANOSTICS
|
Jin Hai Zheng, Jung-Joon Min
|
|
10
|
|
Targeted cancer immunotherapy with engineered Salmonella typhimurium secreting heterologous bacterial flagellin
|
Jin Hai Zheng, Yeongjin Hong, Hyon E. Choy, Joon Haeng Rhee, and Jung-Joon Min
|
|
9
|
|
Engineering of monobody conjugates for humanEphA2-specific optical imaging
|
Min-A Kim, Hee Seung Yoon, Seung-Hwan Park, Dong-Yeon Kim, Ayoung Pyo, Hyeon Sik Kim, Jung-Joon Min, Yeongjin Hong
|
|
8
|
|
Targeted Molecular Theranostics using Engineered Microbes
|
Min, Jung-Joon
|
|
7
|
|
Oncolytic Salmonella-based Cancer Theranostics
|
Jung-Joon Min
|
|
6
|
|
[18F]DMFB, a Novel 18F labeled PET agent for malignant melanoma in small animal models
|
Ayoung Pyo, Misun Yun, Hyeon Sik Kim, Gyeong Min Kim, Byeong-seok Kim, Jinhai Zheng, Dong-Yeon Kin, Jung-Joon Min
|
|
5
|
|
Targeted cancer immunotherapy with engineered Salmonella typhimurium secreting heterologous bacterial flagellin
|
Jung-Joon Min, Jin Hai Zheng, Yeongjin Hong, Hyeon e. Choy, Joon Hang Rhee
|
|
4
|
|
Enhanced cancer immunotherapy using engineered tumor-colonizing Salmonella typhimurium
|
Jin Hai Zheng, Wenzhi Tan, Yeongjin Hong, Shee Eun Lee, Joon Haeng Rhee, and Jung-Joon Min
|
|
3
|
|
Immunotheranostics using Engineered Salmonella typhimurium
|
Jung-Joon Min
|
|
2
|
|
[18F]DMFB, a Novel 18F labeled PET agent for malignant melanoma in small animal
|
민정준
|
|
1
|
|
[18F]DMFB, a Novel 18F labeled PET agent for malignant melanoma in small animal
|
Ayoung Pyo, Misun Yun, Hyeon Sik Kim, Gyeong Min Kim, Byeong-Seok Kim, Jinhai Zheng, Dong-Yeon Kim, Jung-Joon Min
|